Have You Been Diagnosed with Cancer After Taking Belviq?

YOU MAY BE ENTITLED TO FINANCIAL COMPENSATION. COMPLETE THE FORM BELOW FOR A FREE CASE EVALUATION.

AUGUST 6th, 2022: OUR BELVIQ CANCER LAWSUIT LAWYERS ARE CURRENTLY REVIEWING CLAIMS OF INDIVIDUALS WHO HAVE RECEIVED A CANCER DIAGNOSIS AFTER TAKING BELVIQ OR BELVIQ XR

Released and marketed as an adult prescription weight loss drug, Belviq (lorcaserin) has been taken off the market after the FDA revealed an association with the drug and an increased risk for certain types of cancer. Belviq lawsuits have been filed in all 50 states and the personal injury lawyers at Marin and Barrett, Inc. are currently accepting new clients for the Belviq lawsuit who have been diagnosed with cancer after taking Belviq or Belviq XR.

The Belviq lawsuits allege that the makers of popular prescription weight-loss drug Belviq, Eisai Inc. and Arena Pharmaceuticals, failed to warn users of the potential risks and the possibility of the occurrence of cancer after use.  If you or a loved one has been diagnosed with cancer after taking Belviq, contact the aggressive defective drug law firm of Marin and Barrett, Inc. to find out how we can help.  Personal Injury Attorney Marin has been ranked by the SuperLawyers organization as a “Rising Star” and now a “SuperLawyer” from 2014 through 2020. Call to schedule a free, no obligation case evaluation today. Our legal team is available 24/7 at (888) 348-2735 to take your call and stand ready to fight for the money you need and deserve to help you pay your medical costs, future costs and medical bills.

WHAT IS BELVIQ (LORCASERIN)?

Originally approved by the U.S. Food and Drug Administration (FDA) in 2012, Belviq (lorcaserin) is a weight loss drug marketed as a treatment to adult obesity when used in conjunction with diet and exercise. Belviq and Belviq XR act as a serotonin 2c receptor agonist and works as a weight loss stimulant by reducing appetite and increasing the feelings of fullness and satiety. In addition to use as a weight loss supplement, Belviq was prescribed to overweight and obese individuals to treat health issues associated with weight-related health issues such as hypertension (high blood pressure) and diabetes.

Belviq and the extended release version Belviq XR are manufactured by Arena Pharmaceuticals Gmbh in Switzerland and distributed and marketed by Eisai Incorporated out of Woodcliff Lake, New Jersey. When the FDA approved Belviq (lorcaserin) it required the manufacturer to conduct its own double-blind study to determine the safety and efficacy of the drug and evaluate any connections with cardiovascular issues. The randomized, double-blind clinical trial took place with 12,000 obese patients over a five-year study period. While the study found no significant link between use of the drug and cardiovascular complications, it did reveal a link between Belviq use and an increased risk of developing cancer. In the five-year, double-blind study, those taking the prescription drugs Belviq/Belviq XR were more likely to be diagnosed with cancer than those taking a placebo (sugar pill).

On February 13th, 2020, the FDA requested that Arena Phamaceuticals conduct a voluntary recall of Belviq and Belviq extended-release form from the U.S. market due to clinical trials showing a potential cancer link. Long-term use of Belviq frequently resulted in pancreatic, colon cancer, breast cancer, brain cancer and lung cancers in the clinical trial.

LORCASERIN VOLUNTARILY RECALLED IN FEBRUARY 2020 – DOES BELVIQ CAUSE CANCER?

In January 2020, after reviewing the results of the study, the FDA announced that users of the weight loss drug Belviq may face an increased risk of developing cancer. The study found that 462 participants in the study using Belviq developed cancer (at a rate of 7.7%), versus 423 from the placebo-controlled group (a rate of 7.1%). Specifically, Lorcaserin’s cancer risks were associated with a range of cancer types, including:

  • Colorectal Cancer
  • Lung Cancer
  • Pancreatic Cancer

Shortly after announcing its findings the FDA requested that Belviq (lorcaserin) be immediately withdrawn from the market; the drug manufacturer Eisai, Inc. thereafter submitted a request to voluntarily withdraw the medicine from the market. In addition to the Eisai, Inc. withdrawal, the FDA recommended that doctors stop prescribing lorcaserin and that patients stop taking the drug immediately and dispose of the remainder of the drug at a designated drug disposal location or do so properly in their own homes. Letters notifying potential patients and healthcare providers were sent out shortly falling the FDA announcement.

If you or a loved one have been adversely affected after taking Belviq, call Belviq Lawyer Matthew Marin at Marin and Barrett, Inc. today at (888) 348-2735 for a free, no obligation consultation. We can help with your Belviq lawsuit.

CAN A LORCASERIN ATTORNEY HELP ME WITH A LEGAL CLAIM AGAINST BELVIQ IF I HAVE BEEN DIAGNOSED WITH CANCER?​

If you or a loved one developed pancreatic, lung, or colorectal cancer after taking Belviq you may have a claim. You may be entitled to financial compensation for damages, including:

  • Past, present, and future medical expenses including hospital stays
  • Lost wages and lost earning potential
  • Pain and suffering
  • Loss of consortium and loss of enjoyment
  • Punitive damages, if appropriate

In the tragic event that a loved one as died as a result of cancer caused by Belviq or Belviq XR, you may be eligible to file a wrongful death claim. Of course there is no amount of money that can bring them back or fill the void left by their absence, but a claim may cover burial and funeral expenses, pain and suffering, and any past expenses incurred as a result of their illness. Don’t delay, contact personal injury lawyer Matthew Marin today to take legal action and hold the makers of these dangerous drugs accountable for your adverse reactions.

If you or a loved one developed colorectal, lung, or pancreatic cancer after using Belviq you may be entitled to financial compensation. Contact Marin and Barrett, Inc. today. The call and consultation are free and confidential.

BELVIQ ATTORNEY

Have You Been Diagnosed with Cancer After Taking Belviq?

YOU MAY BE ENTITLED TO FINANCIAL COMPENSATION. COMPLETE THE FORM BELOW FOR A FREE CASE EVALUATION.

The Pharmaceutical Industry is an international financial powerhouse, spending $1.2 trillion worldwide and $485 billion in the United States alone in 2018. Do not go it alone, let us fight them for you to get the compensation you rightfully deserve. We work hand in hand with some of the most experienced and respected law firms nationwide and have the resources your case needs to stand toe to toe with pharmaceutical giants.  The makers of Belviq, Eisai, Inc., have profited millions of dollars selling the weight loss drug and need to be held accountable for failing to warn users of the known side effects and potential risk of cancer.

At Marin and Barrett, Inc., we firmly believe that the client’s needs come above all else and have established a fully transparent fee structure to reflect that. We work on a strictly contingency fee basis, meaning that we do not receive anything from you unless we are able to recover money either by settlement or verdict. Regardless of what type of case you have or what is required, you will know everything up front with no surprises. We shoulder the costs of the filing and litigation on your behalf and at no risk to you.​  Additionally, our defective products attorneys can gather your medical records and prescription medications information to begin building a case.

Call our Belviq recall cancer lawsuit attorneys Marin and Barrett, Inc. today (888) 348-2735 to schedule your free consultation and discuss your legal options, it only takes a few moments and there is no obligation.  Don’t delay, as most States have a strict statute of limitations in which your dangerous drug lawsuit must be filed.

ATTORNEY MATTHEW MARIN

  • Admitted in Rhode Island, Connecticut, Massachusetts and South Carolina​
  • ​Assisting clients as a Rhode Island Belviq Cancer Lawyer, South Carolina Belviq Lawyer, Connecticut Belviq Lawyer, and a Massachusetts Belviq Lawyer

ATTORNEY KENSLEY BARETT

  • Admitted in Rhode Island
  • ​Assisting clients as a Rhode Island Belviq Cancer Lawyer

ATTORNEY NICHOLAS PARRILLO

  • Admitted in Rhode Island and Massachusetts
  • Assisting clients as a Rhode Island Belviq Lawyer and a Massachusetts Belviq Lawyer

BELVIQ DISCLAIMER: Do not stop taking a prescribed medication without first consulting with your doctor or health care provider. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.